Incidence

ORIAHNN
(n=395)
Placebo
(n=196)
Hot flush
22% 9%
Headache 9% 7%
Fatigue 6% 4%
Metrorrhagia 5% 1%

Discontinuation

Low discontinuation due to any adverse reactions 

ORIAHNN

10%

Placebo

7%


Less than or equal to 1%

No more than 1% of women taking ORIAHNN discontinued due to any one adverse reaction

Incidence

  ORIAHNN
(n=395)
Placebo
(n=196)
Hot flush
22% 9%
Headache 9% 7%
Fatigue 6% 4%
Metrorrhagia 5% 1%

Low discontinuation due to any adverse reactions 

ORIAHNN

10%

Placebo

7%

No more than 1% of women taking ORIAHNN discontinued due to any one adverse reaction